Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Sci Rep ; 8(1): 16173, 2018 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-30385796

RESUMEN

We previously showed that male Tsumura Suzuki obese diabetes (TSOD) mice, a spontaneous mouse model of metabolic syndrome, manifested gut dysbiosis and subsequent disruption of the type and quantity of plasma short-chain fatty acids (SCFAs), and daily coffee intake prevented nonalcoholic steatohepatitis in this mouse model. Here, we present a preliminary study on whether coffee and its major components, caffeine and chlorogenic acid, would affect the gut dysbiosis and the disrupted plasma SCFA profile of TSOD mice, which could lead to improvement in the liver pathology of these mice. Three mice per group were used. Daily intake of coffee or its components for 16 wk prevented liver lobular inflammation without improving obesity in TSOD mice. Coffee and its components did not repair the altered levels of Gram-positive and Gram-negative bacteria and an increased abundance of Firmicutes in TSOD mice but rather caused additional changes in bacteria in six genera. However, caffeine and chlorogenic acid partially improved the disrupted plasma SCFA profile in TSOD mice, although coffee had no effects. Whether these alterations in the gut microbiome and the plasma SCFA profile might affect the liver pathology of TSOD mice may deserve further investigation.


Asunto(s)
Café/química , Disbiosis/dietoterapia , Ácidos Grasos Volátiles/metabolismo , Inflamación/dietoterapia , Síndrome Metabólico/dietoterapia , Animales , Cafeína/administración & dosificación , Cafeína/química , Ácido Clorogénico/administración & dosificación , Ácido Clorogénico/química , Modelos Animales de Enfermedad , Disbiosis/fisiopatología , Ácidos Grasos Volátiles/química , Microbioma Gastrointestinal/efectos de los fármacos , Humanos , Inflamación/fisiopatología , Hígado/efectos de los fármacos , Hígado/fisiopatología , Síndrome Metabólico/microbiología , Síndrome Metabólico/fisiopatología , Ratones , Ratones Obesos , Obesidad/dietoterapia , Obesidad/fisiopatología
2.
Int Arch Allergy Immunol ; 177(3): 245-254, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30021201

RESUMEN

BACKGROUND: The severity of symptoms of pollen-induced allergic rhinitis is affected by the amount of scattered pollen. However, the relationships between the pollen dispersal pattern, symptom severity, and treatment efficacy are not clear. METHODS: Between 2007 and 2012, we performed 4 randomized, placebo-controlled studies of sublingual immunotherapy (SLIT) on patients with Japanese cedar-induced allergic rhinitis who lived in or around Chiba, Japan. The participants were asked to avoid using rescue medicines during the cedar pollen season as much as possible and to record their nasal symptoms in allergy diaries. The amount of pollen dispersed daily was quantified using the Durham method, and the season was divided into early and late periods based on the pollen count. RESULTS: A total of 721 patients were enrolled in the 4 studies during the 6-year study period. In the placebo group (n = 349), a correlation was observed between the amount of pollen dispersed and the severity of symptoms in the early but not late period of pollen dispersal. Treatment with SLIT (n = 372) significantly improved symptom severity in the late but not early period. CONCLUSION: For patients with Japanese cedar pollen-induced allergic rhinitis, the fluctuation of daily pollen dispersal had a minimal effect on the severity of symptoms during the late period. SLIT was remarkably effective in alleviating symptoms during this period but not in the early period.


Asunto(s)
Antígenos de Plantas/uso terapéutico , Desensibilización Inmunológica/métodos , Proteínas de Plantas/uso terapéutico , Rinitis Alérgica Estacional/patología , Rinitis Alérgica Estacional/terapia , Inmunoterapia Sublingual/métodos , Administración Sublingual , Adolescente , Adulto , Anciano , Antígenos de Plantas/administración & dosificación , Antígenos de Plantas/inmunología , Niño , Cryptomeria/inmunología , Femenino , Humanos , Japón , Masculino , Persona de Mediana Edad , Proteínas de Plantas/administración & dosificación , Proteínas de Plantas/inmunología , Polen/inmunología , Rinitis Alérgica Estacional/inmunología , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Adulto Joven
3.
Sci Rep ; 7(1): 4826, 2017 07 06.
Artículo en Inglés | MEDLINE | ID: mdl-28684736

RESUMEN

Despite recent advances in chemotherapy for gastrointestinal cancer, a crucial factor related to poor prognosis is reduced tolerance to chemotherapy induced by cancer cachexia. Fish oil (FO)-derived eicosapentaenoic acid (EPA) modulates inflammation in patients with various malignancies; however, the impact of FO-enriched nutrition as a combined modality therapy on clinical outcomes remains controversial. We systemically analysed chronological changes in biochemical and physiological status using bioelectrical impedance analysis in 128 gastrointestinal cancer patients provided with or without FO-enriched nutrition during chemotherapy. Furthermore, we evaluated the clinical significance of FO-enriched nutrition and clarified appropriate patient groups that receive prognostic benefits from FO-enriched nutrition during treatment of gastrointestinal cancer. The control group showed significant up-regulation of serum CRP) levels and no significant difference in both skeletal muscle mass and lean body mass. In contrast, the FO-enriched nutrition group showed no changes in serum CRP concentration and significantly increased skeletal muscle mass and lean body mass over time. Furthermore, high CRP levels significantly correlated with reduced tolerance to chemotherapy, and FO-enriched nutrition improved chemotherapy tolerance and prognosis, particularly in gastrointestinal cancer patients with a modified Glasgow prognostic score (mGPS) of 1 or 2. We conclude that FO-enriched nutrition may improve the prognosis of patients with cancer cachexia and systemic inflammation (i.e., those with a mGPS of 1 or 2).


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biomarcadores de Tumor/sangre , Caquexia/dietoterapia , Grasas Insaturadas en la Dieta/administración & dosificación , Ácido Eicosapentaenoico/administración & dosificación , Aceites de Pescado/administración & dosificación , Neoplasias Gastrointestinales/dietoterapia , Anciano , Antígenos de Carbohidratos Asociados a Tumores/sangre , Composición Corporal , Proteína C-Reactiva/metabolismo , Caquexia/tratamiento farmacológico , Caquexia/mortalidad , Caquexia/patología , Antígeno Carcinoembrionario/sangre , Estudios de Cohortes , Femenino , Neoplasias Gastrointestinales/tratamiento farmacológico , Neoplasias Gastrointestinales/mortalidad , Neoplasias Gastrointestinales/patología , Humanos , Inflamación , Masculino , Estado Nutricional , Pronóstico , Análisis de Supervivencia
4.
Metab Syndr Relat Disord ; 15(4): 170-177, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28358620

RESUMEN

BACKGROUND: Metabolic syndrome is one of the most important health issues worldwide. Obesity causes insulin resistance, hyperlipidemia, diabetes, and various diseases throughout the body. The liver phenotype, which is called nonalcoholic steatohepatitis (NASH), frequently progresses to hepatocellular carcinoma. We recently established a new animal model, Tsumura-Suzuki obese diabetic (TSOD) mice, which spontaneously exhibit obesity, diabetes, hyperlipidemia, and NASH with liver nodules. METHODS: We examined the effects of coffee intake on various conditions of the metabolic syndrome using TSOD mice. The daily volume of coffee administered was limited so that it reflected the appropriate quantities consumed in humans. To clarify the effects of the specific components, animals were divided into two coffee-intake groups that included with and without caffeine. RESULTS: Coffee intake did not significantly affect obesity and hyperlipidemia in TSOD mice. In contrast, coffee intake caused various degrees of improvement in the pancreatic beta cell damage and steatohepatitis with liver carcinogenesis. Most of the effects were believed to be caused by a synergistic effect of caffeine with other components such as polyphenols. However, the antifibrotic effects of coffee appeared to be due to the polyphenols rather than the caffeine. CONCLUSIONS: A daily habit of drinking coffee could possibly play a role in the prevention of metabolic syndrome.


Asunto(s)
Café , Células Secretoras de Insulina/efectos de los fármacos , Síndrome Metabólico/tratamiento farmacológico , Enfermedad del Hígado Graso no Alcohólico/prevención & control , Envejecimiento , Animales , Cafeína/uso terapéutico , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/patología , Diabetes Mellitus Tipo 2/prevención & control , Hiperlipidemias/sangre , Células Secretoras de Insulina/patología , Grasa Intraabdominal/efectos de los fármacos , Grasa Intraabdominal/metabolismo , Hígado/patología , Cirrosis Hepática/patología , Cirrosis Hepática/prevención & control , Neoplasias Hepáticas/epidemiología , Neoplasias Hepáticas/prevención & control , Masculino , Síndrome Metabólico/complicaciones , Ratones , Ratones Obesos , Enfermedad del Hígado Graso no Alcohólico/etiología , Enfermedad del Hígado Graso no Alcohólico/patología , Inhibidores de Fosfodiesterasa/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA